MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 192 filers reported holding MYRIAD GENETICS INC in Q3 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $106,954 | -27.1% | 6,668 | +5.3% | 0.00% | – |
| Q2 2023 | $146,775 | -88.2% | 6,332 | -88.2% | 0.00% | -100.0% |
| Q1 2023 | $1,241,829 | +1064.4% | 53,458 | +627.3% | 0.00% | – |
| Q4 2022 | $106,648 | -42.7% | 7,350 | -24.6% | 0.00% | – |
| Q3 2022 | $186,000 | +73.8% | 9,753 | +65.5% | 0.00% | – |
| Q2 2022 | $107,000 | -95.9% | 5,892 | -94.3% | 0.00% | -100.0% |
| Q1 2022 | $2,612,000 | +142.8% | 103,678 | +165.8% | 0.00% | +200.0% |
| Q4 2021 | $1,076,000 | – | 39,013 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,750,000 | $75,900,000 | 2.61% |
| PFM Health Sciences, LP | 2,025,681 | $55,909,000 | 1.90% |
| Tieton Capital Management, LLC | 118,456 | $3,269,000 | 1.83% |
| Altium Capital Management LP | 190,000 | $5,244,000 | 1.45% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,846,490 | $50,963,000 | 1.03% |
| EARNEST PARTNERS LLC | 6,316,365 | $174,332,000 | 1.01% |
| Glenview Capital Management | 1,679,747 | $46,361,000 | 0.99% |
| Zebra Capital Management LLC | 14,209 | $392,000 | 0.63% |
| AIMZ Investment Advisors, LLC | 44,185 | $1,220,000 | 0.48% |
| Phocas Financial Corp. | 132,101 | $3,646,000 | 0.46% |